Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
21 hedge funds and large institutions have $3.88M invested in Orgenesis Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 2 closing their positions.
5% less funds holding
Funds holding: 22 → 21 (-1)
32% less capital invested
Capital invested by funds: $5.67M → $3.88M (-$1.79M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $5K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$16.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.19K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.26K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$390 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$56 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$45K |
| 2 |
Millennium Management
New York
|
-$35K |
| 3 |
BlackRock
New York
|
-$15.7K |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$12.1K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$6.68K |
ORGS Hedge Fund Activity: Q2 2022 in Review
21 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q2 2022, worth a combined $3.88M — down 32% from $5.67M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ORGS and 1 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 4 added.
The largest buyer was Dimensional Fund Advisors, adding an estimated $16.8K. The largest seller was Virtu Financial, exiting entirely with an estimated $45K sold.
- 21 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q2 2022, down from 22 in Q1 2022.
- Funds reported $3.88M of Orgenesis Inc. Common Stock stock for Q2 2022, down 32% quarter-over-quarter.
- 1 fund opened new Orgenesis Inc. Common Stock positions in Q2 2022 and 2 closed out, a net change of -1 holder.
- The largest Orgenesis Inc. Common Stock buyer in Q2 2022 was Dimensional Fund Advisors, an estimated $16.8K added.
- The largest Orgenesis Inc. Common Stock seller in Q2 2022 was Virtu Financial, an estimated $45K sold.
Based on aggregated 13F filings for Q2 2022.